Scarica l'app Stockscreener
1.59
0.63%
-0.01
Dopo l'orario di chiusura:
1.60
0.01
+0.63%
Precedente Chiudi:
$1.60
Aprire:
$1.6
Volume 24 ore:
370.24K
Relative Volume:
0.48
Capitalizzazione di mercato:
$126.77M
Reddito:
$63.63M
Utile/perdita netta:
$10.62M
Rapporto P/E:
31.80
EPS:
0.05
Flusso di cassa netto:
$-8.64M
1 W Prestazione:
+2.58%
1M Prestazione:
+6.00%
6M Prestazione:
-31.47%
1 anno Prestazione:
+57.43%
Intervallo 1D:
$1.56
$1.61
Intervallo di 1 settimana:
$1.5201
$1.6872
Portata 52W:
$0.98
$3.10
Protalix BioTherapeutics Inc. Stock (PLX) Company Profile
Nome
Protalix BioTherapeutics Inc.
Settore
Industria
Telefono
972 4 988 9488
Indirizzo
2 Snunit Street, Science Park PO Box 455, Karmiel
Confronta PLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLX
Protalix BioTherapeutics Inc.
|
1.59 | 130.76M | 63.63M | 10.62M | -8.64M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-06-08 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-17 | Reiterato | Rodman & Renshaw | Buy |
| 2016-04-04 | Iniziato | Rodman & Renshaw | Buy |
| 2015-04-23 | Aggiornamento | Jefferies | Hold → Buy |
| 2014-11-12 | Reiterato | R. F. Lafferty | Buy |
| 2014-01-24 | Iniziato | R. F. Lafferty | Buy |
| 2012-05-02 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2012-05-02 | Reiterato | Oppenheimer | Outperform |
| 2012-04-30 | Downgrade | Auriga | Buy → Hold |
| 2011-10-13 | Iniziato | Morgan Joseph | Hold |
| 2011-03-17 | Downgrade | WBB Securities | Strong Buy → Buy |
| 2010-11-09 | Reiterato | Oppenheimer | Outperform |
| 2010-10-14 | Reiterato | UBS | Buy |
| 2009-12-02 | Reiterato | Hapoalim | Outperform |
| 2009-09-22 | Iniziato | Canaccord Adams | Buy |
| 2009-09-02 | Iniziato | Hapoalim | Outperform |
| 2008-12-01 | Reiterato | Oppenheimer | Outperform |
| 2008-03-11 | Iniziato | UBS | Buy |
| 2007-11-20 | Iniziato | CIBC Wrld Mkts | Sector Outperform |
Mostra tutto
Protalix BioTherapeutics Inc. Borsa (PLX) Ultime notizie
Pattern recognition hints at Protalix BioTherapeutics Inc. upsideQuarterly Portfolio Review & Risk Controlled Daily Plans - Newser
Volume spikes in Protalix BioTherapeutics Inc. stock – what they meanJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
What recovery options are there for Protalix BioTherapeutics Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - Newser
Is it time to cut losses on Protalix BioTherapeutics Inc.Weekly Trading Summary & Fast Entry Momentum Trade Alerts - Newser
What’s next for Protalix BioTherapeutics Inc. stock pricePortfolio Risk Summary & Pattern Based Trade Signal System - Newser
Why Protalix BioTherapeutics Inc. is moving todayJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
What indicators show strength in Protalix BioTherapeutics Inc.Weekly Risk Summary & AI Powered Market Trend Analysis - Newser
Backtesting results for Protalix BioTherapeutics Inc. trading strategiesGold Moves & Capital Efficiency Focused Strategies - Newser
Best data tools to analyze Protalix BioTherapeutics Inc. stock2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Can a trend reversal in Protalix BioTherapeutics Inc. lead to recoveryPortfolio Update Summary & Daily Stock Momentum Reports - Newser
Will Protalix BioTherapeutics Inc. price bounce be sustainable2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Historical volatility pattern of Protalix BioTherapeutics Inc. visualizedDay Trade & Real-Time Price Movement Reports - Newser
Is Protalix BioTherapeutics Inc. stock a buy or sellWeekly Trend Report & Growth Focused Stock Reports - khodrobank.com
Protalix Biotherapeutics shares rise 5.81% intraday after CEO to present at H.C. Wainwright conference. - AInvest
Protalix BioTherapeutics' CEO to present at H.C. Wainwright conference. - AInvest
Plant-Based Protein Therapy Pioneer Protalix BioTherapeutics to Showcase at Global Investment Event - Stock Titan
Is Protalix BioTherapeutics Inc. attractive at current valuation2025 Earnings Impact & Daily Chart Pattern Signals - khodrobank.com
Using R and stats models for Protalix BioTherapeutics Inc. forecastingPortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Why Protalix BioTherapeutics Inc. stock attracts strong analyst attentionMarket Performance Report & Precise Buy Zone Tips - Newser
Is Protalix BioTherapeutics Inc. stock bottoming outJuly 2025 Snapshot & Daily Profit Maximizing Tips - Newser
Is Protalix BioTherapeutics Inc. a strong candidate for buy and holdQuarterly Trade Summary & Free Reliable Trade Execution Plans - khodrobank.com
Protalix BioTherapeutics Q2 Earnings Call: Robust Growth Amid Challenges - AInvest
Protalix BioTherapeutics : PLX Corporate Presentation (August 2025) - MarketScreener
Forecasting Protalix BioTherapeutics Inc. price range with options dataDay Trade & Smart Allocation Stock Reports - Newser
What machine learning models say about Protalix BioTherapeutics Inc.July 2025 EndofMonth & Intraday High Probability Alerts - Newser
Protalix BioTherapeutics Reports Robust Growth Amid Challenges - TipRanks
Will Protalix BioTherapeutics Inc. bounce back from current support2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing Protalix BioTherapeutics Inc. with multi timeframe chartsCPI Data & Capital Protection Trade Alerts - Newser
Applying sector rotation models to Protalix BioTherapeutics Inc.Trend Reversal & High Accuracy Buy Signal Tips - Newser
Trend analysis for Protalix BioTherapeutics Inc. this week2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
Sentiment analysis tools applied to Protalix BioTherapeutics Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - Newser
What MACD signals say about Protalix BioTherapeutics Inc.July 2025 Trends & Target Return Focused Stock Picks - Newser
Protalix BioTherapeutics Inc. Azioni (PLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):